The Philly Wellness Center is offering advanced biochemical testing to help women assess breast and ovarian cancer risk. The ProdromeScan, a laboratory test, measures key biochemical markers from cells, providing a real-time snapshot of health beyond genetic testing.

Owner Catie Harris, Ph.D., MBA, CRNP, explains that while many women know about BRCA mutations, “genes may load the gun, but biochemistry pulls the trigger. Some women with BRCA mutations never develop cancer, while others without them do, because cancer risk also depends on the biochemical environment inside cells.”

Research shows that certain biochemical markers—including low plasmalogens, overactive fatty acid enzymes and markers of oxidative stress—can indicate cancer risk with more than 90 percent accuracy, regardless of BRCA status.

Harris adds, “Identifying and addressing these biochemical weaknesses offers a proactive way to strengthen resilience, long before disease develops.”

Location: 834 South St., Philadelphia. For more information or to make an appointment, call 215-709-9710, email [email protected] or visit www.PhillyWellnessCenter.com.